Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Martine Le Gall"'
Publikováno v:
Clinical & Experimental Allergy. 51:1057-1068
BACKGROUND In line with evidence for a role of pathogenic TH2A in seasonal allergies, we previously showed that individuals suffering from food allergy exhibited a decrease in circulating TH2A cells following multi-food immunotherapy. Herein, we aim
Autor:
Sonia, Luce, Thierry, Batard, Véronique, Bordas-Le Floch, Martine, Le Gall, Laurent, Mascarell
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical ImmunologyREFERENCES. 51(8)
In line with evidence for a role of pathogenic TH2A in seasonal allergies, we previously showed that individuals suffering from food allergy exhibited a decrease in circulating TH2A cells following multi-food immunotherapy. Herein, we aim to confirm
Autor:
Krzysztof Kowal, Peter S. Creticos, Margitta Worm, Philippe Gevaert, Pascal Demoly, Frédéric de Blay, N. Nenasheva, Oliver Pfaar, Miguel Tortajada-Girbés, Carmen Vidal, Jonathan Corren, Thomas B. Casale, Giovanni Passalacqua, Peter Hellings, Martine Le Gall
Publikováno v:
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Journal of Allergy and Clinical Immunology
Journal of Allergy and Clinical Immunology, Elsevier, 2021, 147 (3), pp.1020-1030.e10. ⟨10.1016/j.jaci.2020.07.036⟩
Journal of allergy and clinical immunology, 147(3), 1020-1030.e10. Mosby Inc.
Journal of Allergy and Clinical Immunology, 2021, 147 (3), pp.1020-1030.e10. ⟨10.1016/j.jaci.2020.07.036⟩
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Journal of Allergy and Clinical Immunology
Journal of Allergy and Clinical Immunology, Elsevier, 2021, 147 (3), pp.1020-1030.e10. ⟨10.1016/j.jaci.2020.07.036⟩
Journal of allergy and clinical immunology, 147(3), 1020-1030.e10. Mosby Inc.
Journal of Allergy and Clinical Immunology, 2021, 147 (3), pp.1020-1030.e10. ⟨10.1016/j.jaci.2020.07.036⟩
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Background: Allergic rhinitis induced by house dust mites (HDMs) is a highly prevalent but often underdiagnosed and undertreated/untreated chronic disease. It often has a negative impact on sleep, work, leisure activities, and health-related quality
Autor:
Olivier de Beaumont, Hans-Jørgen Malling, Friedrich Horak, Alain Didier, Margitta Worm, Michel Melac, Gordon Sussman, Martine Le Gall
Publikováno v:
Journal of Allergy and Clinical Immunology. 128:559-566
Seasonal allergic rhinoconjunctivitis affects millions of persons. The efficacy of allergen sublingual immunotherapy (SLIT) was demonstrated in previous short-term studies.We sought to evaluate the sustained efficacy of 2 dosing regimens of a pre- an
Autor:
Andrea Vereda, Stephanie Jean-Alphonse, Lone Agertoft, Jürgen Seidenberg, Susanne Halken, François Payot, Carl-Peter Bauer, María Flora Martín-Muñoz, Ulrich Wahn, Małgorzata Bartkowiak-Emeryk, Martine Le Gall, Michel Melac
Publikováno v:
Pediatric Allergy and Immunology. 21:970-976
The efficacy and safety of five-grass pollen 300IR sublingual immunotherapy (SLIT) tablets (Stallergenes SA, France) have previously been demonstrated in paediatric patients. This report presents additional data concerning efficacy at pollen peak, ef
Publikováno v:
5.3 Allergy and Immunology.
Rationale: The safety and tolerability of sublingual tablets of house dust mite (HDM) allergen extracts at doses up to 2000IR in subjects with HDM-associated allergic asthma have been previously reported. Here we present the impact of short term trea
Publikováno v:
Journal of Allergy and Clinical Immunology. 137:AB404
Autor:
Olivier de Beaumont, Piotr Kuna, Ulrich Wahn, Susanne Halken, A. Montagut, Ana I. Tabar, Martine Le Gall
Publikováno v:
Wahn, U, Tabar, A, Kuna, P, Halken, S, Montagut, A, de Beaumont, O, Le Gall, M & SLIT Study Group 2009, ' Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis ', Journal of Allergy and Clinical Immunology, vol. 123, no. 1, pp. 160-166 . https://doi.org/10.1016/j.jaci.2008.10.009
BACKGROUND: The efficacy and safety of the 300-index of reactivity (IR) dose of 5-grass-pollen sublingual immunotherapy (SLIT) tablets (Stallergènes, Antony, France) have been demonstrated for the treatment of hay fever in adults.OBJECTIVE: We sough
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d766298eeab973aba854546afdf03348
https://portal.findresearcher.sdu.dk/da/publications/e8335d90-f1e8-11dd-9489-000ea68e967b
https://portal.findresearcher.sdu.dk/da/publications/e8335d90-f1e8-11dd-9489-000ea68e967b
Autor:
Friedrich Horak, Philippe Devillier, Michel Melac, Petra Zieglmayer, Philippe Moingeon, René Zieglmayer, Martine Le Gall, A. Montagut, Laurence Van Overtvelt, Patrick Lemell, S. Galvain, Stephanie Jean-Alphonse
Publikováno v:
Journal of Allergy and Clinical Immunology. 124:471-477.e1
Background The efficacy and safety of a 5-grass-pollen sublingual immunotherapy (SLIT) tablet (Stallergenes SA, Antony, France) have been evaluated in clinical studies during the pollen season. The allergen challenge chamber (ACC) has been developed